Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers

Clinical trial NCT05539872 · COMPLETED

Trial details

NCT number: NCT05539872
Sponsor: Amphastar Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Pharmacokinetics Pharmacodynamics

Start date: 2022-08-22
Primary completion: 2023-01-29
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.